- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 534817, 10 pages
Angiotensin II AT1 Receptors Are Involved in Neuronal Activation Induced by Amphetamine in a Two-Injection Protocol
Departamento de Farmacología, Facultad de Ciencias Químicas Universidad Nacional de Córdoba, Instituto de Farmacología Experimental Córdoba (IFEC-CONICET), 5000 Córdoba, Argentina
Received 3 April 2013; Revised 14 June 2013; Accepted 18 June 2013
Academic Editor: Zuoxin Wang
Copyright © 2013 Maria Constanza Paz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. C. Pierce and P. W. Kalivas, “A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants,” Brain Research Reviews, vol. 25, no. 2, pp. 192–216, 1997.
- T. E. Robinson and B. Kolb, “Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine,” Journal of Neuroscience, vol. 17, no. 21, pp. 8491–8497, 1997.
- L. J. M. J. Vanderschuren and P. W. Kalivas, “Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies,” Psychopharmacology, vol. 151, no. 2-3, pp. 99–120, 2000.
- L. J. M. J. Vanderschuren, E. Donné Schmidt, T. J. De Vries, C. A. P. Van Moorsel, F. J. H. Tilders, and A. N. M. Schoffelmeer, “A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats,” Journal of Neuroscience, vol. 19, no. 21, pp. 9579–9586, 1999.
- E. Valjent, J. Bertran-Gonzalez, B. Aubier, P. Greengard, D. Hervé, and J.-A. Girault, “Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol,” Neuropsychopharmacology, vol. 35, no. 2, pp. 401–415, 2010.
- M. C. Paz, M. A. Assis, R. J. Cabrera, L. M. Cancela, and C. Bregonzio, “The AT1 angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol,” Synapse, vol. 65, no. 6, pp. 505–512, 2011.
- L. J. M. J. Vanderschuren, A. N. M. Schoffelmeer, S. D. C. Van Leeuwen, L. Hof, A. J. Jonker, and P. Voorn, “Compartment-specific changes in striatal neuronal activity during expression of amphetamine sensitization are the result of drug hypersensitivity,” European Journal of Neuroscience, vol. 16, no. 12, pp. 2462–2468, 2002.
- D. C. Brown, L. J. Steward, J. Ge, and N. M. Barnes, “Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo,” British Journal of Pharmacology, vol. 118, no. 2, pp. 414–420, 1996.
- J. Tchekalarova, E. Sotiriou, V. Georgiev, G. Kostopoulos, and F. Angelatou, “Up-regulation of adenosine A1 receptor binding in pentylenetetrazol kindling in mice: effects of angiotensin IV,” Brain Research, vol. 1032, no. 1-2, pp. 94–103, 2005.
- J. Tchekalarova and V. Georgiev, “Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?” Life Sciences, vol. 76, no. 9, pp. 955–970, 2005.
- D. L. Daubert, G. G. Meadows, J. H. Wang, P. J. Sanchez, and R. C. Speth, “Changes in angiotensin II receptors in dopamine-rich regions of the mouse brain with age and ethanol consumption,” Brain Research, vol. 816, no. 1, pp. 8–16, 1999.
- F. J. White and P. W. Kalivas, “Neuroadaptations involved in amphetamine and cocaine addiction,” Drug and Alcohol Dependence, vol. 51, no. 1-2, pp. 141–153, 1998.
- M. F. Roitman, E. Na, G. Anderson, T. A. Jones, and I. L. Bernstein, “Induction of a salt appetite alters dendritic morphology in nucleus accumbens and sensitizes rats to amphetamine,” The Journal of Neuroscience, vol. 22, no. 11, article RC225, 2002.
- J. J. Clark and I. L. Bernstein, “Reciprocal cross-sensitization between amphetamine and salt appetite,” Pharmacology Biochemistry and Behavior, vol. 78, no. 4, pp. 691–698, 2004.
- D. Rotllant, C. Márquez, R. Nadal, and A. Armario, “The brain pattern of c-fos induction by two doses of amphetamine suggests different brain processing pathways and minor contribution of behavioural traits,” Neuroscience, vol. 168, no. 3, pp. 691–705, 2010.
- A. Badiani and T. E. Robinson, “Drug-induced neurobehavioral plasticity: the role of environmental context,” Behavioural Pharmacology, vol. 15, no. 5-6, pp. 327–339, 2004.
- J. I. Morgan and T. Curran, “Stimulus-transcription coupling in neurons: role of cellular immediate-early genes,” Trends in Neurosciences, vol. 12, no. 11, pp. 459–462, 1989.
- R. E. Nordquist, L. J. M. J. Vanderschuren, A. J. Jonker et al., “Expression of amphetamine sensitization is associated with recruitment of a reactive neuronal population in the nucleus accumbens core,” Psychopharmacology, vol. 198, no. 1, pp. 113–126, 2008.
- L. F. Franchini and L. Vivas, “Distribution of Fos immunoreactivity in rat brain after sodium consumption induced by peritoneal dialysis,” American Journal of Physiology. Regulatory Integrative and Comparative Physiology, vol. 276, no. 4, pp. R1180–R1187, 1999.
- L. F. Franchini, A. K. Johnson, J. De Olmos, and L. Vivas, “Sodium appetite and Fos activation in serotonergic neurons,” American Journal of Physiology. Regulatory Integrative and Comparative Physiology, vol. 282, no. 1, pp. R235–R243, 2002.
- G. Paxinos, The Rat Brain in Stereotaxic Coordinates, Elsevier, Oxford, 2009.
- B. Xue, Z. Zhang, R. F. Johnson, and A. K. Johnson, “Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment,” Hypertension, vol. 59, no. 2, pp. 459–466, 2012.
- M. J. Acerbo and A. K. Johnson, “Behavioral cross-sensitization between DOCA-induced sodium appetite and cocaine-induced locomotor behavior,” Pharmacology Biochemistry and Behavior, vol. 98, no. 3, pp. 440–448, 2011.
- E. Moellenhoff, A. Blume, J. Culman et al., “Effect of repetitive icv injections of ANG II on c-Fos and AT1-receptor expression in the rat brain,” American Journal of Physiology. Regulatory Integrative and Comparative Physiology, vol. 280, no. 4, pp. R1095–R1104, 2001.
- A. C. Voorhies and I. L. Bernstein, “Induction and expression of salt appetite: effects on Fos expression in nucleus accumbens,” Behavioural Brain Research, vol. 172, no. 1, pp. 90–96, 2006.
- G. Simonnet and M. F. Giorguieff-Chesselet, “Stimulating effect of angiotensin II on the spontaneous release of newly synthesized [3H]dopamine in rat striatal slices,” Neuroscience Letters, vol. 15, no. 2-3, pp. 153–158, 1979.
- G. Simonnet, M. F. Giorguieff-Chesselet, and A. Carayon, “Angiotensin II and nigrostriatal system,” Journal de Physiologie, vol. 77, no. 1, pp. 71–79, 1981.
- P. W. Kalivas and J. Stewart, “Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity,” Brain Research Reviews, vol. 16, no. 3, pp. 223–244, 1991.
- L. J. M. J. Vanderschuren, T. J. De Vries, G. Wardeh, F. A. C. M. Hogenboom, and A. N. M. Schoffelmeer, “A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats,” European Journal of Neuroscience, vol. 14, no. 9, pp. 1533–1538, 2001.
- T. E. Robinson, P. A. Jurson, J. A. Bennett, and K. M. Bentgen, “Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats,” Brain Research, vol. 462, no. 2, pp. 211–222, 1988.
- V. Georgiev, S. Stancheva, T. Kambourova, and D. Getova, “Effect of angiotensin II on the vogel conflict paradigm and on the content of dopamine and noradrenaline in rat brain,” Acta Physiologica et Pharmacologica Bulgarica, vol. 16, no. 1, pp. 32–37, 1990.
- M. S. Todtenkopf, A. Mihalakopoulos, and J. R. Stellar, “Withdrawal duration differentially affects c-fos expression in the medial prefrontal cortex and discrete subregions of the nucleus accumbens in cocaine-sensitized rats,” Neuroscience, vol. 114, no. 4, pp. 1061–1069, 2002.
- A. M. Pacchioni, M. Cador, C. Bregonzio, and L. M. Cancela, “A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress,” Neuropsychopharmacology, vol. 32, no. 3, pp. 682–692, 2007.
- I. Armando, S. Volpi, G. Aguilera, and J. M. Saavedra, “Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress,” Brain Research, vol. 1142, no. 1, pp. 92–99, 2007.
- C. Bregonzio, A. Seltzer, I. Armando, J. Pavel, and J. M. Saavedra, “Angiotensin II AT1 receptor blockade selectively enhances brain AT2 receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats,” Stress, vol. 11, pp. 457–466, 2008.
- J. M. Saavedra, H. Ando, I. Armando et al., “Brain angiotensin II, an important stress hormone: regulatory sites and therapeutic opportunities,” Annals of the New York Academy of Sciences, vol. 1018, pp. 76–84, 2004.
- J. M. Saavedra, H. Ando, I. Armando et al., “Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists,” Regulatory Peptides, vol. 128, no. 3, pp. 227–238, 2005.
- J. M. Saavedra, I. Armando, C. Bregonzio et al., “A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF 1 receptor and benzodiazepine binding,” Neuropsychopharmacology, vol. 31, no. 6, pp. 1123–1134, 2006.
- L. I. Perrotti, C. A. Bolaños, K.-H. Choi et al., “ΔFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment,” European Journal of Neuroscience, vol. 21, no. 10, pp. 2817–2824, 2005.